GI Dynamics Company Profile (ASX:GID)

About GI Dynamics (ASX:GID)

GI Dynamics logoGI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: ASX:GID
  • CUSIP: N/A
  • Web: www.gidynamics.com/
Average Prices:
  • 50 Day Moving Avg: A$0.06
  • 200 Day Moving Avg: A$0.05
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
Dividend:
  • Dividend Yield: 1.0%
Profitability:
  • Net Margins: -2,642.16%
  • Return on Equity: -195.93%
  • Return on Assets: -140.97%
 
Frequently Asked Questions for GI Dynamics (ASX:GID)

What is GI Dynamics' stock symbol?

GI Dynamics trades on the ASX under the ticker symbol "GID."

Who are some of GI Dynamics' key competitors?

Who are GI Dynamics' key executives?

GI Dynamics' management team includes the folowing people:

  • Scott Schorer, President, Chief Executive Officer
  • James B. Murphy, Chief Financial Officer, Treasurer, Company Secretary
  • Brian Callahan, Executive Vice President - Clinical, Regulatory and Quality, Chief Compliance Officer
  • Karl-Heinz Blohm Ph.D., Vice President - International Sales
  • Daniel Jeffrey Moore, Non-Executive Chairman of the Board
  • Timothy Joseph Barberich, Independent Non-Executive Director
  • Graham John Bradley, Independent Non-Executive Director
  • Anne Jillian Keating, Independent Non-Executive Director
  • Oern R. Stuge M.D., Independent Non-Executive Director


MarketBeat Community Rating for GI Dynamics (ASX GID)
Community Ranking:  0.9 out of 5 ()
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  13 (Vote Underperform)
Total Votes:  16
MarketBeat's community ratings are surveys of what our community members think about GI Dynamics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for GI Dynamics (ASX:GID) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for GI Dynamics (ASX:GID)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for GI Dynamics (ASX:GID)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for GI Dynamics (ASX:GID)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for GI Dynamics (ASX:GID)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for GI Dynamics (ASX:GID)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for GI Dynamics (ASX:GID)
Latest Headlines for GI Dynamics (ASX:GID)
Source:
DateHeadline
businesswire.com logoGI Dynamics Selects Proven Process Medical Devices as Contract Manufacturer - Business Wire (press release)
www.businesswire.com - July 25 at 7:20 PM
finance.yahoo.com logoGI Dynamics Selects Proven Process Medical Devices as Contract Manufacturer
finance.yahoo.com - July 25 at 7:20 PM
finance.yahoo.com logoGI Dynamics Announces EndoBarrier Data to be Presented at Digestive Disease Week
finance.yahoo.com - July 5 at 2:13 PM
finance.yahoo.com logoGI Dynamics Announces Scientific Advisory Board Members to Further Development of EndoBarrier
finance.yahoo.com - July 5 at 2:13 PM
finance.yahoo.com logoGI Dynamics Announces EndoBarrier CE Mark Suspension
finance.yahoo.com - July 5 at 2:13 PM
finance.yahoo.com logoGI Dynamics Announces Access to 2017 Annual Meeting of Stockholders and Corporate Update
finance.yahoo.com - July 5 at 2:13 PM
finance.yahoo.com logoMeta-Analysis Show EndoBarrier Improves Glycemic Control, Induces Weight Loss in Patients with Type 2 Diabetes and Obesity
finance.yahoo.com - July 5 at 2:13 PM
finance.yahoo.com logoGI Dynamics Announces Change to Board of Directors
finance.yahoo.com - July 5 at 2:13 PM
finance.yahoo.com logoGI Dynamics Releases EndoBarrier Re-Implantation Data from German Diabetes Congress
finance.yahoo.com - July 5 at 2:13 PM
finance.yahoo.com logoFirst Data Derived from ABCD Worldwide EndoBarrier Registry Presented at ADA Shows Sustained Metabolic Improvements in Patients with Obesity and Type 2 Diabetes at Six Months Post-explant
finance.yahoo.com - July 5 at 2:13 PM
finance.yahoo.com logoGI Dynamics Announces $5m Convertible Note Financing with Crystal Amber Fund
finance.yahoo.com - July 5 at 2:13 PM
finance.yahoo.com logoGI Dynamics Announces Additional Members to Its Scientific Advisory Board
finance.yahoo.com - July 5 at 2:13 PM

Social

Social activity is not available for this stock.
This page was last updated on 7/27/2017 by MarketBeat.com Staff